Other languages Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Delayed London S.E. Other stock markets 06:32:28 2024-06-28 EDT			5-day change	1st Jan Change
4.6 ^GBX	-4.17%		+4.55%	-36.55%

05-23	Windward wins deal; Kodal progresses at Bougouni	AN
05-23	Roquefort Therapeutics plc Announces Executive and Board Changes	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Windward wins deal; Kodal progresses at Bougouni	05-23
Roquefort Therapeutics plc Announces Executive and Board Changes	05-23
EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany	04-26
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-26
Roquefort cancels fundraise after "unusual" stock movements	04-05
Roquefort celebrates "significant milestones" in cancer research	03-11
Roquefort Therapeutics plc Provides an Update on the Development of the Midkine Midkine mRNA and STAT-6 siRNA programs	03-11
Roquefort hails further MK studies, licence talks continue	02-06
Roquefort Therapeutics plc Provides an Update on Its Pre-Clinical Drug Development Programs	02-06
Roquefort Therapeutics Announces Significant Mesodermal Killer Cell Milestone	11-06
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO	23-09-27
Roquefort Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-27
Roquefort files patent application for mRNA and RNA therapies	23-08-14
Roquefort Therapeutics Files International Patent for Anti-cancer Therapeutics	23-08-14
Roquefort Therapeutics plc Announces the Successful Filing of the International Phase PCT Patent for Its Proprietary Anti-Cancer mRNA and RNA Oligonucleotide Therapeutics	23-08-14
Roquefort announces new sirNA sequences and patent filing	23-08-07
Roquefort Therapeutics Completes Development of Four Novel Small Interfering RNA Sequences; Shares Up 5%	23-08-07
Anpario trading in line, Likewise Group sales rise	23-06-29
Plant Health Care announces GBP2.8 million fundraise	23-06-22
Roquefort Therapeutics Expects Q4 Closing for In Vivo Studies for Anti-Cancer Program	23-06-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Other languages

Filters